|
S. No.
|
Title
|
Funding Agency
|
Amount
(lakh)
|
Duration
|
|
COMPLETED
|
|
1.
|
Nano-carriers for co-delivery of small molecules and oligonucleotides
|
BITS, Pilani
|
2.00
|
2014-1026
|
|
2.
|
Development of Nano-Carriers for Improved Drug Delivery.
|
BITS, Pilani
|
9.90
|
2015-2017
|
|
3.
|
Combination delivery of small molecules and microRNA for treatment of locally advanced and metastatic breast cancer.
|
DST-SERB
|
27.20
|
2015-2018
|
|
4
|
Exploring the synergism of PPARγ agonist and HDAC inhibitor or on reversal of Alzheimer's type of dementia and developing their brain targeted nano-carrier system for effective treatment.
|
DST-Nanomission
|
31.13
|
2017-2020
|
|
5.
|
Nanotechnology based pharmaceuticals, nutraceuticals and cosmetics: development of platform technology.
|
Incisive Element LLC, USA
|
21.37
|
2017-2020
|
|
6.
|
Peptide-decorated pH-sensitive nano-conjugate hybrid micelles for co-delivery of temozolamide and an autophagy inducer, rapamycin, for treatment of glioblastoma multiforme.
|
DBT-Nanobiotechnology
|
41.962
|
2018-2021
|
|
7.
|
cRGD decorated lipo-polymeric nanoplexes of CRISPR/Cas9 ribonucleoprotein (RNP) for the management of retinal dystrophic conditions
|
DBT-Nano-intervention in Management of Opthalmic Diseases
|
125.214
|
2018-2022
|
|
8.
|
Actively targeted nano-formulations for co-delivery of a taxane and antioxidant molecule, alpha lipoic acid, for treating breast cancer.
|
DST-Rajasthan
|
11.136
|
2018-2021
|
|
ONGOING PROJECTS (As Principle Investigator)
|
|
1
|
Setting up a DST supported Technology Enabling Center (TEC) at BITS Pilani
|
DST-TDT Division
(As co-ordinator)
|
Recommended
|
|
2.
|
Methylated cfDNA as a pathological biomarker for the development of a CRISPR/Cas based molecular diagnostic tool
|
DST Interdisciplinary Cyber-Physical Systems (NM-ICPS)
|
38.5712
|
15th Sept 2022-
14th March 2023
|
|
3.
|
DBT-BUILDER -University of Birla Institute of Technology and Science Pilani, Pilani Campus Interdisciplinary Life Science Programme for Advanced Research and Education in Epigenetics and Genome editing
|
DBT-BUILDER
(As PI team member)
|
901.80320
|
25th Sept 2021-
24th Sept 2026
|
|
4
|
Self-assembling, pH-sensitive temozolomide conjugate nanomedicine for treatment of glioblastoma multiforme,
|
ICMR
|
25.22
|
24th Sept 2019-
24th Sept’ 2022
|
|
As co-investigator
|
|
1.
|
Gel-based composite formulation containing asiaticoside and neurotensin for rapid healing of diabetic wounds.
|
ICMR
|
29.83
|
2019-2022
|
|
2.
|
Peptide-tethered multifunctional cationic nanocomplexes for delivery of IL-1
receptor antagonist for
|
DST-SERB
|
40.4695
|
2020-2023
|
An Institute of Eminence
